BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Press Releases

  Theriva Biologics Announces Presentation of Data from the Phase 1b/2a Clinical Trial of SYN-004 (ribaxamase) in Allogeneic Hematopoietic Cell Transplant Recipients

  April 11, 2025

   · 

  7 min read
• Press Releases

  Ottimo Pharma Strengthens Board with Appointment of Roger Dansey, M.D. to its Board of Directors

  April 11, 2025

   · 

  3 min read
• Press Releases

  Recce Pharmaceuticals Announces A$5.0 million Placement & Launches A$10.8 million Entitlement Offer to Shareholders

  April 11, 2025

   · 

  8 min read
• Press Releases

  Harvard Bioscience Announces CFO Transition

  April 11, 2025

   · 

  3 min read
• Press Releases

  Crinetics Pharmaceuticals Announces April 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 10, 2025

  April 11, 2025

   · 

  2 min read
• Press Releases

  Gerresheimer: Bormioli Pharma boosts revenues and earnings

  April 11, 2025

   · 

  4 min read
• Press Releases

  FibroBiologics to Present at The Cell & Gene Meeting on the Mediterranean

  April 11, 2025

   · 

  1 min read
• Press Releases

  Malaria Vaccines Market Size to Reach USD 1,432.7 Mn by 2032, Growing at 12.7% CAGR, says Coherent Market Insights

  April 11, 2025

   · 

  1 min read
• Press Releases

  BIOQUAL Presents Unaudited Financial Results for Third Quarter of Fiscal Year 2025

  April 11, 2025

   · 

  1 min read
• FDA

  U.S. Food and Drug Administration Approves Opdivo® (nivolumab) plus Yervoy® (ipilimumab) as a First-Line Treatment for Unresectable or Metastatic Hepatocellular Carcinoma

  April 11, 2025

   · 

  19 min read